Information Links
Mims
Main Navigation
Drugs
Conditions
News and resources
MIMS HostedMental health news
Non-drug therapies as, or more, effective than drugs for dementia patients with depression, research suggests
Researchers identified 10 non-drug interventions associated...
Pregabalin linked to severe respiratory depression in absence of opioids
The MHRA advises prescribers to consider adjustment...
Stay alert to postpartum bleeding risk with antidepressants, MHRA warns
Observational data suggest that the use of SSRIs and...
Proposed withdrawal of bipolar disorder treatment revoked
The manufacturer of first-line bipolar disorder treatment...
Stop withdrawal of bipolar disorder treatment, health secretary urged
GPs, pharmacists, psychiatrists and patients are calling...
Women taking valproate still unaware of pregnancy risks, survey finds
One in ten women currently taking valproate are unaware...
New guidance for minimising psychological impact of COVID-19 pandemic in primary care patients
A group of clinicians and public health experts have...
Beta blocker overdose warning
The toxicity of a commonly prescribed beta blocker...
Melatonin 'should not be prescribed on NHS for jet lag'
It is 'inappropriate' to make melatonin available on...
Ketamine-derived nasal spray provides new option for resistant depression
Spravato (esketamine) works in a different way to existing...
Avoid benzodiazepines in opioid-dependent patients, GPs reminded
Prescribing benzodiazepines in opioid-dependent individuals...
Serious shortage protocol for fluoxetine 10mg capsules revoked
The Government has withdrawn one of the three serious...
HRT and antidepressant shortages prompt export ban and pharmacist scrip-switching
The government has banned exports of HRT products and...
Potentially addictive medicines 'being prescribed for years'
Hundreds of thousands of people are receiving prescriptions...
Mirtazapine no more effective than placebo as an additive antidepressant
Mirtazapine is unlikely to provide any clinical benefit...
Gabapentin and pregabalin to be subject to tighter controls
From April 2019 gabapentin and pregabalin will be reclassified...
Antidepressant withdrawal 'much greater problem than guidelines suggest'
The incidence, severity and duration of antidepressant...
New atypical antipsychotic offers potential benefits in treatment of schizophrenia
Reagila (cariprazine) is an orally active partial agonist...
Doctors identify 50 'unnecessary' medical interventions
A list of 50 tests, treatments and procedures 'of questionable...
Anticholinergics linked to increased dementia risk
Patients prescribed certain types of anticholinergic...
MIMS Clinics
Prescribing news and resources for key therapeutic areas, collated by the MIMS editors.